EMPLOYMENT AGREEMENTEmployment Agreement • August 10th, 2012 • Adma Biologics, Inc. • Blank checks • New Jersey
Contract Type FiledAugust 10th, 2012 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is effective as of the 18th day of July, 2012 (the “Effective Date”) by and between ADMA Biologics, Inc., a Delaware corporation with its principal place of business at 65 Commerce Way, Hackensack, NJ 07601-6302 (the “Company”), and James Mond, MD (the “Executive”).
ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] PLASMA SUPPLY AGREEMENTPlasma Supply Agreement • August 10th, 2012 • Adma Biologics, Inc. • Blank checks • Delaware
Contract Type FiledAugust 10th, 2012 Company Industry JurisdictionTHIS PLASMA SUPPLY AGREEMENT (“Agreement”) between Biotest Pharmaceuticals Corporation, a Delaware corporation, having a place of business at 5800 Park of Commerce Boulevard NW, Boca Raton, Florida 33487 (“BPC”) and ADMA Biologics, Inc., a Delaware corporation, having a place of business at 65 Commerce Way, Hackensack, New Jersey 07601 (“ADMA”) shall be effective as of June 22, 2012 (the “Effective Date”). BPC and ADMA are each sometimes referred to herein individually as a “Party” or collectively as the “Parties.”
ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] Testing Services AgreementTesting Services Agreement • August 10th, 2012 • Adma Biologics, Inc. • Blank checks • New Jersey
Contract Type FiledAugust 10th, 2012 Company Industry JurisdictionTHIS TESTING SERVICES AGREEMENT (“the Agreement”) is made effective as of the date last signed below (the “Effective Date”) by and between Quest Diagnostics Clinical Laboratories, Inc. (“Quest Diagnostics”), with a principal office located at 1201 South Collegeville Road, Collegeville, PA 19426, and ADMA Biologics, Inc. with a principal office located at 65 Commerce Way, Hackensack, NJ 07601 (“Client”) for protocol number Screening and Recertification 2012 (the “Project”). Quest Diagnostics and Client shall each herein be referred to as a “Party” and together as the “Parties.”